skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,269  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Female remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
AR101 Oral Immunotherapy for Peanut Allergy
Material Type:
Article
Add to My Research

AR101 Oral Immunotherapy for Peanut Allergy

The New England journal of medicine, 2018-11, Vol.379 (21), p.1991-2001 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812856 ;PMID: 30449234

Full text available

2
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Material Type:
Article
Add to My Research

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Nature chemical biology, 2019-07, Vol.15 (7), p.747-755 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jul 2019 ;ISSN: 1552-4450 ;EISSN: 1552-4469 ;DOI: 10.1038/s41589-019-0304-8 ;PMID: 31209351

Full text available

3
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Material Type:
Article
Add to My Research

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Rheumatology, 2021-02, Vol.60 (2), p.820-828 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1462-0324 ;ISSN: 1462-0332 ;EISSN: 1462-0332 ;EISSN: 1460-2172 ;DOI: 10.1093/rheumatology/keaa393 ;PMID: 32810263

Full text available

4
A new antibiotic kills pathogens without detectable resistance
Material Type:
Article
Add to My Research

A new antibiotic kills pathogens without detectable resistance

Nature (London), 2015-01, Vol.517 (7535), p.455-459 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jan 22, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14098 ;PMID: 25561178 ;CODEN: NATUAS

Full text available

5
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Material Type:
Article
Add to My Research

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

The lancet oncology, 2022-01, Vol.23 (1), p.91-103 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00591-X ;PMID: 34895487

Full text available

6
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Material Type:
Article
Add to My Research

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

The New England journal of medicine, 2022-02, Vol.386 (7), p.640-654 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116133 ;PMID: 34891224

Full text available

7
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
Material Type:
Article
Add to My Research

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Annals of the rheumatic diseases, 2022-01, Vol.81 (1), p.143-145 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-220549 ;PMID: 34556483

Full text available

8
Asymmetric spiroacetalization catalysed by confined Bronsted acids
Material Type:
Article
Add to My Research

Asymmetric spiroacetalization catalysed by confined Bronsted acids

Nature (London), 2012-03, Vol.483 (7389), p.315-319 [Peer Reviewed Journal]

2015 INIST-CNRS ;2012 Macmillan Publishers Limited. All rights reserved ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Mar 15, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature10932 ;PMID: 22422266 ;CODEN: NATUAS

Full text available

9
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
Material Type:
Article
Add to My Research

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

American journal of clinical dermatology, 2021-07, Vol.22 (4), p.567-579 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 ;Copyright Springer Nature B.V. Jul 2021 ;ISSN: 1175-0561 ;EISSN: 1179-1888 ;DOI: 10.1007/s40257-021-00598-4 ;PMID: 33786754

Full text available

10
Spider Silk: From Soluble Protein to Extraordinary Fiber
Material Type:
Article
Add to My Research

Spider Silk: From Soluble Protein to Extraordinary Fiber

Angewandte Chemie (International ed.), 2009-05, Vol.48 (20), p.3584-3596 [Peer Reviewed Journal]

Copyright © 2009 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;ISSN: 1433-7851 ;EISSN: 1521-3773 ;DOI: 10.1002/anie.200803341 ;PMID: 19212993

Full text available

11
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease
Material Type:
Article
Add to My Research

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease

Alimentary pharmacology & therapeutics, 2020-06, Vol.51 (11), p.1031-1038 [Peer Reviewed Journal]

2020 John Wiley & Sons Ltd ;2020 John Wiley & Sons Ltd. ;Copyright © 2020 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.15719 ;PMID: 32329532

Full text available

12
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Material Type:
Article
Add to My Research

Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (6), p.905-910 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-212825 ;PMID: 29592917

Full text available

13
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Material Type:
Article
Add to My Research

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

The New England journal of medicine, 2020-07, Vol.383 (1), p.85-88 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2009567 ;PMID: 32348641

Full text available

14
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Material Type:
Article
Add to My Research

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.795-810 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2015-208840 ;PMID: 26888948 ;CODEN: ARDIAO

Full text available

15
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Material Type:
Article
Add to My Research

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

Journal of clinical oncology, 2018-06, Vol.36 (17), p.1658-1667 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.73.7379 ;PMID: 28981385

Full text available

16
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
Material Type:
Article
Add to My Research

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1914-1920 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2011 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2011.151043 ;PMID: 21791449 ;CODEN: ARDIAO

Full text available

17
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists
Material Type:
Article
Add to My Research

Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2017-10, Vol.31 (5), p.447-459 [Peer Reviewed Journal]

Springer International Publishing AG 2017 ;Copyright Springer Science & Business Media Oct 2017 ;ISSN: 1173-8804 ;EISSN: 1179-190X ;DOI: 10.1007/s40259-017-0244-3 ;PMID: 28929342

Full text available

18
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
Material Type:
Article
Add to My Research

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Journal of clinical oncology, 2021-09, Vol.39 (27), p.3034-3043 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00377 ;PMID: 34133196

Full text available

19
Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor Cells
Material Type:
Article
Add to My Research

Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor Cells

The Journal of immunology (1950), 2020-11, Vol.205 (10), p.2707-2718 [Peer Reviewed Journal]

Copyright © 2020 by The American Association of Immunologists, Inc. ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.2000731 ;PMID: 33028617

Full text available

20
Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes
Material Type:
Article
Add to My Research

Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes

Digestive diseases and sciences, 2019-06, Vol.64 (6), p.1660-1667 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2019 Springer ;Digestive Diseases and Sciences is a copyright of Springer, (2018). All Rights Reserved. ;Springer Science+Business Media, LLC, part of Springer Nature 2018. ;ISSN: 0163-2116 ;EISSN: 1573-2568 ;DOI: 10.1007/s10620-018-5406-8 ;PMID: 30535885

Full text available

Results 1 - 20 of 3,269  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,088)

Refine My Results

Creation Date 

From To
  1. Before 1975  (28)
  2. 1975 To 1987  (101)
  3. 1988 To 1999  (114)
  4. 2000 To 2012  (579)
  5. After 2012  (2,447)
  6. More options open sub menu

Language 

  1. English  (3,225)
  2. Japanese  (335)
  3. German  (25)
  4. Spanish  (13)
  5. Portuguese  (12)
  6. Polish  (3)
  7. French  (3)
  8. Russian  (2)
  9. Norwegian  (2)
  10. Chinese  (2)
  11. Swedish  (1)
  12. Arabic  (1)
  13. Turkish  (1)
  14. Icelandic  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait